How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

This article is part of “The Young American Scientists,” which includes stories of 28 extraordinary scientists poised to change the world, as well as a deep look at the past, present and future of ...

David Sacks, Donald Trump’s former White House AI Czar, has publicly slammed Anthropic following the release of the AI safety lab’s massive, 10,000-word research paper warning about the catastrophic ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...

Sakana AI has opened a Recursive Self-Improvement Lab to test whether AI systems can help redesign and optimize future AI systems, a bet aimed at reducing frontier AI’s dependence on brute-force ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

OpenAI and Sam Altman aim to automate AI research. They are now hiring for a role to prepare the company for self-training AI.

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...